Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1986 1
2010 1
2011 1
2014 1
2022 2
2023 2
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection.
Nick JA, Dedrick RM, Gray AL, Vladar EK, Smith BE, Freeman KG, Malcolm KC, Epperson LE, Hasan NA, Hendrix J, Callahan K, Walton K, Vestal B, Wheeler E, Rysavy NM, Poch K, Caceres S, Lovell VK, Hisert KB, de Moura VC, Chatterjee D, De P, Weakly N, Martiniano SL, Lynch DA, Daley CL, Strong M, Jia F, Hatfull GF, Davidson RM. Nick JA, et al. Among authors: lovell vk. Cell. 2022 May 26;185(11):1860-1874.e12. doi: 10.1016/j.cell.2022.04.024. Epub 2022 May 13. Cell. 2022. PMID: 35568033 Free PMC article.
Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP study.
Nick JA, Martiniano SL, Lovell VK, Vestal B, Poch K, Caceres SM, Rysavy NM, de Moura VC, Gilick JJ, Malcolm KC, Pacheco J, Amin AG, Chatterjee D, Daley CL, Kasperbauer S, Gross JE, Armantrout E, Cohen KA, Keck A, Vandalfsen JM, Magaret AS, Midamba N, Chapdu C, Gao A, Hill JE, Freeman KG, Cristinziano M, Guerrero C, Jacobs-Sera D, Lauer MJ, Viland M, Hatfull GF; Investigators of the Cystic Fibrosis NTM Consortium. Nick JA, et al. Among authors: lovell vk. J Cyst Fibros. 2025 Jul;24(4):684-690. doi: 10.1016/j.jcf.2025.03.669. Epub 2025 Apr 12. J Cyst Fibros. 2025. PMID: 40222858 Free article.
Culture independent markers of nontuberculous mycobacterial (NTM) lung infection and disease in the cystic fibrosis airway.
Nick JA, Malcolm KC, Hisert KB, Wheeler EA, Rysavy NM, Poch K, Caceres S, Lovell VK, Armantrout E, Saavedra MT, Calhoun K, Chatterjee D, Aboellail I, De P, Martiniano SL, Jia F, Davidson RM. Nick JA, et al. Among authors: lovell vk. Tuberculosis (Edinb). 2023 Jan;138:102276. doi: 10.1016/j.tube.2022.102276. Epub 2022 Nov 17. Tuberculosis (Edinb). 2023. PMID: 36417800 Free PMC article.
Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study.
Martiniano SL, Caceres SM, Poch K, Rysavy NM, Lovell VK, Armantrout E, Jones M, Anthony M, Keck A, Nichols DP, Vandalfsen JM, Sagel SD, Wagner B, Xie J, Weaver K, Heltshe SL, Daley CL, Davidson RM, Nick JA; Investigators of the Cystic Fibrosis NTM Consortium. Martiniano SL, et al. Among authors: lovell vk. J Cyst Fibros. 2024 Jan;23(1):50-57. doi: 10.1016/j.jcf.2023.08.007. Epub 2023 Sep 4. J Cyst Fibros. 2024. PMID: 37666709 Free PMC article.
Early effects of the San Francisco paid sick leave policy.
Colla CH, Dow WH, Dube A, Lovell V. Colla CH, et al. Among authors: lovell v. Am J Public Health. 2014 Dec;104(12):2453-60. doi: 10.2105/AJPH.2013.301575. Epub 2014 Jan 16. Am J Public Health. 2014. PMID: 24432927 Free PMC article.
Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis.
Calhoun KM, Armantrout E, Poch K, Caceres S, Lovell VK, Jones M, Malcolm KC, Vestal B, Wheeler E, Rysavy N, Manzer J, Aboellail I, Chatterjee D, Nick JA. Calhoun KM, et al. Among authors: lovell vk. medRxiv [Preprint]. 2024 Aug 9:2024.08.08.24311698. doi: 10.1101/2024.08.08.24311698. medRxiv. 2024. Update in: PLoS One. 2025 Mar 10;20(3):e0309191. doi: 10.1371/journal.pone.0309191. PMID: 39148848 Free PMC article. Updated. Preprint.
Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis.
Calhoun KM, Armantrout E, Poch K, Caceres S, Lovell VK, Jones M, Malcolm KC, Vestal B, Wheeler E, Rysavy N, Manzer J, Aboellail I, Chatterjee D, Nick JA. Calhoun KM, et al. Among authors: lovell vk. PLoS One. 2025 Mar 10;20(3):e0309191. doi: 10.1371/journal.pone.0309191. eCollection 2025. PLoS One. 2025. PMID: 40063876 Free PMC article.
11 results